Testing a blood test to monitor bleeding disorder treatment

Researchers are working to create a better blood test to monitor how well marstacimab and other treatments work for severe hemophilia. Right now, the available blood tests don't reliably show whether these treatments are actually preventing bleeding in patients, even though the tests show improvement in the lab. This study will help develop a more accurate test that doctors can use to manage patients better, especially during surgery or serious bleeding episodes.

When doctors treat hemophilia with newer medications, they need reliable blood tests to know if the treatment is working well enough to prevent dangerous bleeding. Currently available tests don't match what actually happens to patients in real life, leaving doctors without clear guidance for managing care in critical situations.